Rising demand for personalized medicines is a key factor driving the global transcriptomics market, says Fortune Business Insights in a report, titled “Transcriptomics Market Size, Share and Global Trend By Technology (Polymerase Chain Reaction (PCR), Microarray, Next-Generation Sequencing (NGS)), By Application (Drug Discovery, Clinical Diagnostics, Toxicogenomics), By End-User (Academic and Research Institutes, Pharmaceutical Companies, Biotechnology Companies) and Geography Forecast till 2026.” Rapid innovations and improvements in healthcare infrastructure is expected to aid the growth of the global transcriptomics market.
According to the report, the increasing demand for transcriptomics due to its DNA microarrays and next-generation sequencing technologies has impelled new companies to enter the market. This factor will encourage the growth of the global transcriptomics market. For instance, in April 2017, Seven Bridges, a biomedical data analysis company announced a financial investment in Spatial Transcriptomics AB, a life science start-up, which is developing innovative technology to analyze tissue samples in two dimensions.
The report provides a comprehensiveoverview of the transcriptomics industry.Itoffers insights into factors enablibg growth in the global transcriptomics market. The study focuses on the recent product launches and acquisitions by leading market players.
Transcriptomics Highlights of the Report:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the Supply Chain Analytics market.
- Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Supply Chain Analytics market
What does the Report Include?
The market report includes qualitative and quantitative analysis of several factors such as the key drivers and restraints that will impact growth. Additionally, the report provides insights into the regional analysis that covers different regions, contributing to the growth of the market. It includes the competitive landscape that involves the leading companies and the adoption of strategies to announce partnerships, introduce new products, and collaborate that will further contribute to the growth of the market between 2020 and 2027. Moreover, the research analyst has adopted several research methodologies such as SWOT and PESTEL analysis to extract information about the current trends and industry developments that will drive the market growth during the forecast period.
The COVID-19 pandemic has had a seismic effect on several economies across the globe. To curb the pandemic spread, the governments of several countries have ordered complete lockdown of industrial and human activities. This is expected to have a significant impact on the market in 2020. However, proactive steps by the industry leaders to revive the Healthcare industry will bode well for the growth of the market in the near future.
Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Out research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers and acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.
Increasing R&D Investments Will Propel Growth
The rapid adoption of transcriptomics and increasing demand for personalized medicine is expected to boost the global transcriptomics market revenue during the forecast period. Further, the launch of MI Transcriptome, an advanced gene profiling product is expected to stimulate the growth of the global transcriptomics market. For instance,Caris Life Sciences launched an advanced gene profiling product, MI Transcriptome which enables Whole Transcriptome Sequencing (WTS). The newly developed technology has the capability to provide in detail RNA sequencing analysis. In addition, growing number of biopharmaceutical companies and rising expenditure on research and development is predicted to further enable the growth of the global transcriptomics market.
Launch Of CORALL Will Favor Growth
Lexogen, a transcriptomics company focused on the development of innovative kits and software for RNA-Seq, launched CORALL-Total RNA-Seq Library Prep Kit. The new kit will be utilized in transcriptome analysis.Moreover,the acquisition of Spatial Transcriptomics by 10x Genomics is expected to uplift theglobal transcriptomics market shares during the forecast period. For instance, 10x Genomics acquired Spatial Transcriptomics, a potential player in spatial genomics.Nonetheless, lack of skilled professionals in emerging nations is likely to restrict the global transcriptomics market growth during the forecast period.
Rising Prevalence Of Chronic Disorders Will Enable Growth In North America
Geographically, the global transcriptomics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global transcriptomics market owing to the rising demand for personalized medicines and growing cases of chronic disorders such as cancer and others. In addition, rising investment in the research and development of transcriptomics technologies will further accelerate growth in North America. Asia Pacific is expected to grow at a significant CAGR during the forecast period due to the increasing number of pharmaceutical and biotechnology companies in the region. Moreover, high demand for transcriptomics technologies and increasing investments in R&D and drug development will further boost growth in Asia Pacific.
Enquire before buying:
Some of the major companies operating in the global transcriptomics market are:
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Agilent Technologies
- GE Healthcare Dharmacon Inc.
- Bio-Rad Laboratories, Inc.
- Hoffmann-La Roche Ltd.
- Merck & Co., Inc.
- Fluidigm Corporation
- Promega Corporation
- and others.
Browse more information on this Report: https://www.fortunebusinessinsights.com/industry-reports/transcriptomics-market-101227
ALSO READ | Fortune Business Insights
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.